METASTATIC HEPATOCELLULAR CARCINOMA
Clinical trials for METASTATIC HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-phase study tests several new drug combinations in people with advanced solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if the drugs can shrink tumors. About 352 adults with specific cancer types will participate…
Matched conditions: METASTATIC HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 16, 2026 22:47 UTC
-
Engineered immune cells take on tough liver cancer in early trial
Disease control TerminatedThis early-phase study tests a new treatment for adults with advanced liver cancer that has not responded to at least two standard therapies. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells that have a specific p…
Matched conditions: METASTATIC HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug cocktail plus targeted procedure shows promise for tough liver cancers
Disease control OngoingThis study tests whether combining three drugs (durvalumab, bevacizumab, tremelimumab) with a liver procedure called TACE can help people with advanced liver or bile duct cancer live longer without their cancer growing. About 27 adults with intermediate or advanced liver cancer o…
Matched conditions: METASTATIC HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New combo therapy shows promise for HIV patients with advanced cancer
Disease control OngoingThis early-phase trial is testing the safety of combining two cancer drugs—nivolumab and cabozantinib—in people with HIV who have advanced solid tumors. The study includes 8 participants with various cancers that have spread. The goal is to see if the combination can shrink or st…
Matched conditions: METASTATIC HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New combo shows promise for Tough-to-Treat bile duct cancer
Disease control OngoingThis study tests a new drug called pevonedistat, given alone or with standard chemotherapy (paclitaxel and carboplatin), in people with advanced bile duct cancer that has spread or cannot be removed. The goal is to see if the combination can shrink tumors. About 40 adults who hav…
Matched conditions: METASTATIC HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 24, 2026 16:05 UTC